Nama Insights

GSK plc (GSK)

Healthcare · Drug Manufacturers General · NYSE

GSK plc (GSK) is a Healthcare company in the Drug Manufacturers General industry. It has a market capitalization of $106.07B, a trailing price-to-earnings ratio of 11.1 and a free-cash-flow yield of 5.9%. Over the most recent reported fiscal year, revenue grew 4.1% and free cash flow per share grew 34.0%.
Market cap$106.07B
Trailing P/E11.1
FCF yield5.9%
Revenue growth (YoY)+4.1%
EPS growth (YoY)+13.3%
FCF/share growth (YoY)+34.0%
ExchangeNYSE
SectorHealthcare
IndustryDrug Manufacturers General
Explore live GSK data on Nama Insights →

Recent Congressional trades

GSK plc trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Lisa McClain House Sell $1,001 - $15,000 Nov 1, 2025
Lisa McClain House Sell $1,001 - $15,000 Nov 1, 2025
Valerie Hoyle House Sell $1,001 - $15,000 Sep 23, 2025
Valerie Hoyle House Buy $1,001 - $15,000 Sep 11, 2025
Lisa McClain House Buy $1,001 - $15,000 Aug 13, 2025
Lisa McClain House Buy $1,001 - $15,000 Aug 13, 2025
Robert B. Aderholt House Sell $1,001 - $15,000 Aug 11, 2025
Bruce Westerman House Sell $1,001 - $15,000 Apr 28, 2025
Bruce Westerman House Buy $1,001 - $15,000 Mar 17, 2025
Marjorie Taylor Mrs Greene House Buy $1,001 - $15,000 Nov 26, 2024
Daniel Goldman House Sell $15,001 - $50,000 Aug 4, 2023
Virginia Foxx House Buy $1,001 - $15,000 Aug 16, 2022